Cold Urticaria

Dermatology
1
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Celldex Therapeutics
1 program
1
CDX-0159Phase 11 trial
Active Trials
NCT04548869Completed41Est. May 2023

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Celldex TherapeuticsCDX-0159

Clinical Trials (1)

Total enrollment: 41 patients across 1 trials

NCT04548869Celldex TherapeuticsCDX-0159

A Single Dose Study of the Safety, Pharmacokinetics and Pharmacodynamics of CDX-0159 in Patients With Cold Contact Urticaria, Symptomatic Dermographism, or Cholinergic Urticaria

Start: Nov 2020Est. completion: May 202341 patients
Phase 1Completed

Related Jobs in Dermatology

MSL/Senior MSL, Dermatology - Tampa, Florida

AbbVie
Remote
13h ago

(Senior) Außendienstmitarbeiter Dermatology (all genders) - Region Thüringen

AbbVie
Remote
13h ago

Regional Sales Trainer - Dermatology (Central / West Regions)

AbbVie
Remote
14h ago

Regional Sales Trainer - Dermatology (Northeast / Southeast Regions)

AbbVie
Remote
14h ago

Delegado Especialista Ventas Dermatología (Inmunología)

AbbVie
Remote
18h ago

Senior Manager, HTA, Value and Evidence (HV&E), Medical Dermatology

Pfizer
United States - New York - New York City
Yesterday
$139K - $232K/yr

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 companies competing in this space

Related Indications

Dermatitis, Atopic(42)Hidradenitis Suppurativa(30)Chronic Spontaneous Urticaria(21)Alopecia Areata(17)Hidradenitis Suppurativa (HS)(10)Vitiligo(9)Rosacea(6)Chronic Urticaria(5)Pruritus(5)Androgenetic Alopecia(5)